| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective
|
Ovsyannikova, Alla K.
|
|
2016
|
7 |
3 |
p. 591-600
|
artikel
|
| 2 |
A Practical Approach to Gastrointestinal Complications of Diabetes
|
Maisey, Abigail
|
|
2016
|
7 |
3 |
p. 379-386
|
artikel
|
| 3 |
Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
|
Ostawal, Amrita
|
|
2016
|
7 |
3 |
p. 411-438
|
artikel
|
| 4 |
Clinical Effects and Safety of Direct-Acting Insulin Analogs in Patients with Type 1 Diabetes: A Nation-Wide Observational Cohort Study
|
Lak, Vincent
|
|
2016
|
7 |
3 |
p. 561-573
|
artikel
|
| 5 |
Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers
|
Green, William
|
|
2016
|
7 |
3 |
p. 511-525
|
artikel
|
| 6 |
Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
|
Bannister, Margaret
|
|
2016
|
7 |
3 |
p. 387-399
|
artikel
|
| 7 |
Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study
|
Khattab, Mohamed
|
|
2016
|
7 |
3 |
p. 551-560
|
artikel
|
| 8 |
How Much Time Do Families Spend on the Health Care of Children with Diabetes?
|
Miller, Jane E.
|
|
2016
|
7 |
3 |
p. 497-509
|
artikel
|
| 9 |
Improving Type 2 Diabetes Patient Health Outcomes with Individualized Continuing Medical Education for Primary Care
|
Lee, Brian
|
|
2016
|
7 |
3 |
p. 473-481
|
artikel
|
| 10 |
Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?
|
Gentile, Sandro
|
|
2016
|
7 |
3 |
p. 401-409
|
artikel
|
| 11 |
Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records
|
Kolaczynski, Wlodzimierz M.
|
|
2016
|
7 |
3 |
p. 483-496
|
artikel
|
| 12 |
Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes
|
Jones, Gregory C.
|
|
2016
|
7 |
3 |
p. 575-582
|
artikel
|
| 13 |
Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims Study
|
Roussel, Ronan
|
|
2016
|
7 |
3 |
p. 537-549
|
artikel
|
| 14 |
Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes
|
Baron, Kyle T.
|
|
2016
|
7 |
3 |
p. 455-471
|
artikel
|
| 15 |
Postprandial Glucagon Reductions Correlate to Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in Type 2 Diabetes Mellitus: A Post Hoc Analysis
|
Ahrén, Bo
|
|
2016
|
7 |
3 |
p. 583-590
|
artikel
|
| 16 |
Practical Approaches to Diabetes Care: An Introduction
|
Evans, Marc
|
|
2016
|
7 |
3 |
p. 377
|
artikel
|
| 17 |
Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment
|
Perl, Shira
|
|
2016
|
7 |
3 |
p. 527-535
|
artikel
|
| 18 |
Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment
|
Thomas, Merlin C.
|
|
2016
|
7 |
3 |
p. 439-454
|
artikel
|
Tijdschrift beschrijving